Acylin Therapeutics
Total Raised
$4MInvestors Count
8Deal Terms
1Funding, Valuation & Revenue
3 Fundings
Acylin Therapeutics has raised $4M over 3 rounds.
Acylin Therapeutics's latest funding round was a Asset Sale for on January 1, 2014.
Acylin Therapeutics's valuation in December 2010 was $7.36M.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
1/1/2014 | Asset Sale | Acquirer | 1 | |||
6/4/2012 | Series A - II | |||||
12/16/2010 | Series A | $7.36M |
Date | 1/1/2014 | 6/4/2012 | 12/16/2010 |
|---|---|---|---|
Round | Asset Sale | Series A - II | Series A |
Amount | |||
Investors | Acquirer | ||
Valuation | $7.36M | ||
Revenue | |||
Sources | 1 |
This profile has not been claimed.
You're more than your latest funding, tell our customers your company's story.
Acylin Therapeutics Deal Terms
1 Deal Term
Acylin Therapeutics's deal structure is available for 1 funding round, including their Series A from December 16, 2010.
Round | Series A |
|---|---|
Funding Date | |
Pre-Money Valuation | |
Post-Money Valuation | |
Amount Raised | |
Shares Authorized | |
Issuance Price | |
Dividend Rate | |
Liquidation Preferences | |
Liquidation Price | |
Participation | |
Conversion Price | |
Anti Dilution | |
General Voting | |
Board Voting | |
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series A |
Acylin Therapeutics Investors
8 Investors
Acylin Therapeutics has 8 investors. ARCH Venture Partners invested in Acylin Therapeutics's Series A funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
12/16/2010 | 6/4/2012 | 2 Series A - II, Series A (2010) | Venture Capital | Illinois | ||
Venture Capital | Washington | |||||
Venture Capital | Washington | |||||
Corporate Venture | California | |||||
Corporation | North Carolina |
First funding | 12/16/2010 | ||||
|---|---|---|---|---|---|
Last Funding | 6/4/2012 | ||||
Investor | |||||
Rounds | 2 Series A - II, Series A (2010) | ||||
Board Seats | |||||
Type | Venture Capital | Venture Capital | Venture Capital | Corporate Venture | Corporation |
Location | Illinois | Washington | Washington | California | North Carolina |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.